rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP

NCT01525836 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

123

Enrollment

OTHER

Sponsor class

Conditions

Purpura
Idiopathic Thrombocytopenic Purpura

Interventions

DRUG: rituximab; recombinant human thrombopoietin (rhTPO)
DRUG: Rituximab

Sponsor

Shandong University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]